05/05/2024, 08:00
Investors are eyeing IMP’s pharmaceutical stocks as potential hot picks
Imexpharm’s achievement of being in the top 8% of domestic drug manufacturers meeting group 1 & 2 bidding standards in the ETC channel is a testament to its focus on...